Scientists test new drug delivery device for cancer support medication
NCT ID NCT07416955
Summary
This study compared two versions of a drug called pegfilgrastim, which helps boost white blood cells. It involved 180 healthy adults who each received both a new auto-injector version and an existing syringe version of the drug. The main goal was to see if the two versions behaved the same way in the body and were equally safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cliantha Research
St. Petersburg, Florida, 33714, United States
Conditions
Explore the condition pages connected to this study.